Imipramine Pamoate Capsules 125 mg, 30-count bottle, Rx only, Manufactured for Lupin…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Recalling firm

Lupin Pharmaceuticals Inc.

NDC code

68180-316-06

Origin

MD, United States

Initiated by

Voluntary: Firm initiated

FDA recall number

D-0027-2022

Other Imipramine recalls

See all

Class III · Low risk Terminated Jul 16, 2015

Imipramine HCl Tablets, USP, 50 mg, 100 count bottles, Mfd By: Mutual Pharmaceutical Co., Inc., Philadelphia, PA --- NDC…

Reason Chemical Contamination; benzophenone leached from the product label varnish

Mutual Pharmaceutical Company, Inc. NDC 54738-914-01 D-1425-2015

Class III · Low risk Terminated Jul 16, 2015

Imipramine HCl Tablets, USP, 25 mg, 100 count bottles, Mfd By: Mutual Pharmaceutical Co., Inc., Philadelphia, PA --- NDC…

Reason Chemical Contamination; benzophenone leached from the product label varnish

Mutual Pharmaceutical Company, Inc. NDC 54738-913-01 D-1424-2015

Class III · Low risk Terminated Jul 16, 2015

Imipramine HCl Tablets, USP, 10 mg, 100 count bottles, Rx only, Mfd By: Mutual Pharmaceutical Co. Inc., Philadelphia, PA --- NDC…

Reason Chemical Contamination; benzophenone leached from the product label varnish

Mutual Pharmaceutical Company, Inc. NDC 54738-912-01 D-1423-2015

Class II · Moderate risk Terminated Jul 2, 2013

IMIPRAMINE HCL, Tablet, 25 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 00781176401.

Reason Labeling: Label Mixup: IMIPRAMINE HCL, Tablet, 25 mg may have potentially been mislabeled as the following drug: FENOFIBRATE, Tablet, 54 mg, NDC…

Aidapak Services, LLC D-1002-2014